Lord, Abbett & Co. LLC United Therapeutics Corp Transaction History
Lord, Abbett & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Lord, Abbett & Co. LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 201,695 shares of UTHR stock, worth $75 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
201,695
Previous 201,695
-0.0%
Holding current value
$75 Million
Previous $72.3 Million
-0.0%
% of portfolio
0.23%
Previous 0.24%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
676Shares Held
42.1MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.64 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.18 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.06 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$832 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.9B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...